Executive Summary
1 Market Overview
1.1 Introduction
1.2 Market Definition
1.3 Significant Applications
1.4 Different Types of Synthesized Oligonucleotides
1.5 Global Footprint

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Increasing Inline and Strong Pipeline of Oligonucleotides
2.2.2 Rising Consolidation in the Market
2.2.3 Increasing Incidence of Cancer and Chronic Diseases
2.3 Restraints
2.3.1 Regulatory Complexity
2.4 Opportunity
2.4.1 Positive Future Outlook
2.4.2 Growth in Developing Countries
2.5 Challenges
2.5.1 Difficult Therapeutic Classification Due to Wide Variety of Oligonucleotides
2.5.2 Challenging Drug Delivery

3 Competitive Landscape
3.1 Key Strategies and Developments
3.1.1 Product Launches and Enhancements
3.1.2 Acquisitions
3.1.3 Synergistic Activities
3.1.4 Business Expansion Activities
3.2 Market Share Analysis
3.3 Growth Share Analysis

4 Industry Insights
4.1 Industry Trends
4.1.1 Oligonucleotide Microarray Boosts Market Expansion
4.1.2 Drug Pipeline Analysis
4.1.3 Oligonucleotide Synthesis Down the Line

5 Global Oligonucleotide Synthesis Market, By Product, 2018-2029 ($Million)
5.1 Introduction
5.2 Synthesized Oligonucleotides
5.2.1 Synthesized Oligonucleotides, By Product
5.2.1.1 Primers
5.2.1.2 Probes
5.2.1.3 Large-Scale Synthesized Oligonucleotides
5.2.1.4 Intermediate-scale synthesized oligonucleotides
5.2.1.5 Linkers and Adaptors
5.2.2 Synthesized Oligonucleotides, By Type
5.2.3 Custom Oligonucleotides
5.2.4 Pre-designed oligonucleotides
5.3 Equipment
5.4 Reagent
5.5 Services

6 Global Oligonucleotide Synthesis Market, By Application, 2018-2029 ($Million)
6.1 Overview
6.2 Research
6.2.1 Polymerase Chain Reaction
6.2.2 qPCR
6.2.3 Next-Generation Sequencing
6.2.4 Gene Synthesis
6.2.5 Other Research Application
6.3 Therapeutics
6.3.1 DNA and Antisense Oligonucleotide-Based Therapies
6.3.2 RNA Oligonucleotides Therapies
6.3.3 Other Therapeutic Applications
6.4 Diagnostics

7 Global Oligonucleotide Synthesis Market, By End User, 2018-2029 ($Million)
7.1 Overview
7.2 Academic Research Institutes
7.3 Pharmaceutical and Biotechnology Companies
7.4 Diagnostic Laboratories

8 Global Oligonucleotide Synthesis Market, By Region, 2018-2029 ($Million)
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest-of-Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest-of-Asia-Pacific
8.5 Latin America
8.6 Middle East and Africa

9 Company Profiles
9.1 Overview
9.2 Agilent Technologies
9.2.1 Company Overview
9.2.2 Role of Agilent Technologies in the global oligonucleotide synthesis market
9.2.3 Financials
9.2.4 Key Insights about Financial Health of the Company
9.2.5 SWOT Analysis
9.3 ATDBio Ltd.
9.3.1 Company Overview
9.3.2 Role of ATDBio Ltd. in the global oligonucleotide synthesis market
9.3.3 SWOT Analysis
9.4 Bio-Synthesis Inc.
9.4.1 Company Overview
9.4.2 Role of Bio-Synthesis Inc. in the global oligonucleotide synthesis market
9.4.3 SWOT Analysis
9.5 Eurofins Scientific SE
9.5.1 Company Overview
9.5.2 Role of Eurofins Scientific SE in the global oligonucleotide synthesis market
9.5.3 Financials
9.5.4 SWOT Analysis
9.6 Kaneka Eurogentec S.A.
9.6.1 Company Overview
9.6.2 Role of Kaneka Eurogentec S.A. in the global oligonucleotide synthesis market
9.6.3 SWOT Analysis
9.7 General Electric Company
9.7.1 Company Overview
9.7.2 Role of General Electric Company in the global oligonucleotide synthesis market
9.7.3 Financials
9.7.4 Key Insights about Financial Health of the Company
9.7.5 SWOT Analysis
9.8 TriLink BioTechnologies, LLC
9.8.1 Company Overview
9.8.2 Role of TriLink BioTechnologies, LLC in the global oligonucleotide synthesis market
9.8.3 SWOT Analysis
9.9 GenScript Biotech Corp
9.9.1 Company Overview
9.9.2 Role of GenScript Biotech Corp in the global oligonucleotide synthesis market
9.9.3 Financials
9.9.4 Key Insights about Financial Health of the Company
9.9.5 SWOT Analysis
9.10 Ajinomoto Co., Inc.
9.10.1 Company Overview
9.10.2 Role of Ajinomoto Co., Inc. in the global oligonucleotide synthesis market
9.10.3 Financials
9.10.4 Key Insights about Financial Health of the Company
9.10.5 SWOT Analysis
9.11 Biolegio B.V.
9.11.1 Company Overview
9.11.2 Role of Biolegio B.V. in the global oligonucleotide synthesis market
9.11.3 SWOT Analysis
9.12 Danaher Corporation
9.12.1 Company Overview
9.12.2 Role of Danaher Corporation in the global oligonucleotide synthesis market
9.12.3 Financials
9.12.4 Key Insights about Financial Health of the Company
9.12.5 SWOT Analysis
9.13 Microsynth AG
9.13.1 Company Overview
9.13.2 Role of Microsynth AG in the global oligonucleotide synthesis market
9.13.3 SWOT Analysis
9.14 Merck KGaA
9.14.1 Company Overview
9.14.2 Role of Merck KGaA in the global oligonucleotide synthesis market
9.14.3 Financials
9.14.4 Key Insights about Financial Health of the Company
9.14.5 SWOT Analysis
9.15 LGC Limited
9.15.1 Company Overview
9.15.2 Role of LGC Limited in the global oligonucleotide synthesis market
9.15.3 Financials
9.15.4 Key Insights about Financial Health of the Company
9.15.5 SWOT Analysis
9.16 Thermo Fisher Scientific Inc.
9.16.1 Company Overview
9.16.2 Role of Thermo Fisher Scientific Inc. in the global oligonucleotide synthesis market
9.16.3 Financials
9.16.4 Key Insights about Financial Health of the Company
9.16.5 SWOT Analysis

10 Research Scope and Methodology
10.1 Research Scope
10.2 Global Oligonucleotide Synthesis Market: Research Methodology